Our Bristol Myers Squibb Stock Pick Is Up 35%. It's Still a Good Bet in Healthcare.来源:Barrons发布于 2026-11-12The stock is still attractive trading at 10 times forward earnings.相关标的:BMY继续访问返回新闻本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。